Partially Folded Glycated State of Human Serum Albumin Tends to Aggregate

  • Taqi Ahmed Khan
  • M. Saleemuddin
  • Aabgeena Naeem


The interaction of reducing carbohydrates with proteins leads to a cascade of reactions that are known as glycation or Maillard reactions that results in the formation of advanced glycation end products. We studied the impact of incubation with various sugars for 4 weeks on the behaviour of human serum albumin incubation using CD, fluorescence, UV–Vis spectrophotometry and polyacrylamide gel electrophoresis. Three weeks of incubation of human serum albumin with sugars resulted in the formation of an intermediate state with negative CD peaks at 222 and 208 nm characteristic of α-helix. The form also retained tertiary contacts but with altered tryptophan environment and high ANS binding indicative of molten globule state. Further incubation of human serum albumin for 4 weeks resulted in the formation of an intermediate form with negative CD peak at 217 nm, characteristic of β-sheet, decreased ANS fluorescence and increased thioflavin T fluorescence characteristic of an aggregated state. Prolonged exposure of human serum albumin to reducing sugars thus exerts greater deleterious effects on its structure and formation of aggregates.


AGEs Aggregation Circular dichorism Fluorescence HSA Molten globule 





Advanced glycation end products


Human serum albumin




Circular dichorism


Polyacrylamide gel electrophoresis

Th T

Thioflavin T


Receptor for AGEs


Trinitrobenzene sulphonate



Financial support from the Department of Science and Technology, New Delhi in the form of project (SR/FT/LS-087/2007) and CSIR in the form of project No. 37(1365)/09/EMR-II is gratefully acknowledged. The authors are highly thankful for the facilities obtained at AMU Aligarh.


  1. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H (1994) Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Nat1 Acad Sci USA 91:9441–9445Google Scholar
  2. Chesne S, Rondeau P, Armenta S, Bourdon E (2006) Effects of oxidative modifications induced by the glycation of bovine serum albumin on its structure and on cultured adipose cells. Biochimie 88:1467–1477PubMedCrossRefGoogle Scholar
  3. Cussons PJ, Jacoby J, McKay A, Kelly SM, Price NC, Hunt JV (1997) Glucose modification of human serum albumin: a structural study. Free Radic Biol Med 22:1217–1228CrossRefGoogle Scholar
  4. Fink AL (1998) Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold Des 3(1):9–23CrossRefGoogle Scholar
  5. Ge F, Jiang L, Liu D, Chen C (2011) Interaction between alizarin and human serum albumin by fluorescence spectroscopy. Anal Sci 27(1):79–84PubMedCrossRefGoogle Scholar
  6. Guthrow CE, Morris MA, Day JF, Thorpe SR, Baynes JW (1979) Enhanced nonenzymatic glycosylation of human serum albumin in diabetes mellitus. Proc Nat1 Acad Sci USA 76(9):4258–4261CrossRefGoogle Scholar
  7. Haghani K, Khajeh K, Salmanian AH, Ranjbar B, Bakhtiyari S (2011) Acid-induced formation of molten globule states in the wild type Escherichia coli 5-enolpyruvylshikimate 3-phosphate synthase and its three mutated forms: G96A, A183T and G96A/A183T. Protein J 30(2):132–137PubMedCrossRefGoogle Scholar
  8. Hand M, Filova E, Kubala M, Lansky Z, Kolacna L, Vorlicek J, Trc T, Amler E (2007) Fluorescent advanced glycation end products in the detection of factual stages of cartilage degeneration. Physiol Res 56:235–242Google Scholar
  9. Haynes R, Osuga DT, Feeney RE (1967) Modification of amino groups in inhibitors of proteolytic enzymes. Biochemistry 6:541–547PubMedCrossRefGoogle Scholar
  10. He XM, Carter DC (1992) Atomic structure and chemistry of human serum albumin. Nature 358:209–215PubMedCrossRefGoogle Scholar
  11. Hu D, Qin Z, Xue B, Fink AL, Uversky VN (2008) The effect of methionine oxidation on structural properties, conformational stability, and aggregation of immunoglobulin light chain LEN. Biochemistry 47(33):8665–8677PubMedCrossRefGoogle Scholar
  12. Iberg N, Fluckinger R (1986) Nonenzymatic glycosylation of albumin in vitro (Identification of multiple glycosylated sites). J Biol Chem 261:13542–13545PubMedGoogle Scholar
  13. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 227:680–685PubMedCrossRefGoogle Scholar
  14. Leclere J, Birlouez-Aragon I (2001) The fluorescence of advanced maillard products is a good indicator of lysine damage during the maillard reaction. J Agric Food Chem 49:4682–4687PubMedCrossRefGoogle Scholar
  15. LeVine H (1999) Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol 309:274–284PubMedCrossRefGoogle Scholar
  16. Lo TW, Westwood ME, McLellan AC, Selwood T, Thornalley PJ (1994) Binding and modification of proteins by methylglyoxal under physiological conditions: a kinetic and mechanistic study with N-acetylarginine, N-acetylcysteine, N-acetyllysine, and bovine serum albumin. J Biol Chem 269:32299–32305PubMedGoogle Scholar
  17. Lowry OH, Rosenberg NJ, Randall AL (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  18. Mera K, Takeo K, Izumi M, Maruyama T, Nagai R, Otagiri M (2009) Effect of reactive-aldehydes on the modification and dysfunction of human serum albumin. J Pharm Sci 99:1614–1625Google Scholar
  19. Naeem A, Fazili NA (2011) Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins. Cell Biochem Biophys. doi: 10.1007/s12013-011-9200-x
  20. Naeem A, Khan TA, Muzaffar M, Ahmad S, Saleemuddin M (2011) A partially folded state of ovalbumin at low pH tends to aggregate. Cell Biochem Biophys 59(1):29–38PubMedCrossRefGoogle Scholar
  21. Nagai R, Matsumoto K, Ling X, Suzuli H, Araki T, Horiuchi S (2000) Glycoaldehyde, a reactive intermediate for advance glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes 49:1714–1723PubMedCrossRefGoogle Scholar
  22. Prasanna Kumari NK, Jagannadham MV (2011) SDS induced molten globule state of heynein; a new thiol protease: evidence of domains and their sequential unfolding. Colloid Surf B Biointerfaces 82(2):609–615CrossRefGoogle Scholar
  23. Sen D, Mandal DK (2011) Pea lectin unfolding reveals a unique molten globule fragment chain. Biochimie 93(3):409–417PubMedCrossRefGoogle Scholar
  24. Sjodin T, Hansson R, Sjoholm I (1977) Isolation and identification of a trypsin-resistant fragment of human serum albumin with bilirubin- and drug-binding properties. Biochim Biophys Acta 494:61–75PubMedGoogle Scholar
  25. Sjoholm I, Ljungstedt I (1973) Studies on the tryptophan and drug-binding properties of human serum albumin fragments by affinity chromatography and circular dichroism measurements. J Biol Chem 248:8434–8441PubMedGoogle Scholar
  26. Sunde M, Blake CCF (1997) The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv Protein Chem 50:123–159PubMedCrossRefGoogle Scholar
  27. Takatsy A, Boddi K, Nagy L, Nagy G, Szabo S, Marko L, Wittmann I, Ohmacht R, Ringer T, Bonn GK, Gjerde D, Szabo Z (2009) Enrichment of Amadori products derived from the nonenzymatic glycation of proteins using microscale boronate affinity chromatography. Anal Biochem 393:8–22PubMedCrossRefGoogle Scholar
  28. Tseng JY, Ghazaryan AA, Lo W, Chen YF, Hovhannisyan V, Chen SJ, Tan HY, Dong CY (2011) Multiphoton spectral microscopy for imaging and quantification of tissue glycation. Biomed Opt Express 2(2):218–230CrossRefGoogle Scholar
  29. Uversky VN, Narizhneva NV, Ivanova TV, Tomashevski AY (1997) Rigidity of human α-fetoprotein tertiary structure is under ligand control. Biochemistry 36:13638–13645PubMedCrossRefGoogle Scholar
  30. Valencia JV, Weldon SC, Quinn D, Kiers GH, Degroot J, TeKoppele JM, Huges TE (2004) Advanced glycation end products: biochemical characterization and formation kinetics. Anal Biochem 324:68–78PubMedCrossRefGoogle Scholar
  31. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A (1994) Advanced glycation end product contribute to amyloidosis in Alzheimer disease. Proc Nat1 Acad Sci USA 91:4766–4770Google Scholar
  32. Wang Y, King JA, Alvardo MR, Kelly JW, Dobson CM (2010) Cataract as a protein-aggregation disease. In: Protein misfolding diseases: current and emerging principles and therapies. John Wiley & Sons Inc., pp 487–515Google Scholar
  33. Westwood ME, Thornalley PJ (1995) Molecular characteristics of methylglyoxal-modified and human serum albumins. Comparison with glucose-derived advanced glycation endproducts-modified serum albumins. J Protein Chem 14:359–372PubMedCrossRefGoogle Scholar
  34. Xie W, Wan O, Wan C, Kenny KK (2010) New insights into the role of mitochondrial dysfunction and protein aggregation in Parkinson’s disease. Biochim Biophys Acta Mol Bas Dis 1802(11):935–941Google Scholar
  35. Yamamoto Y, Sakata N, Meng J, Sakamoto M, Noma A, Maeda I, Okamoto K, Takebayashi S (2002) Possible involvement of increased glycooxidation and lipid peroxidation of elastin in aethrogenesis in haemodialysis patients. Nephrol Dial Transplant 17:630–636PubMedCrossRefGoogle Scholar
  36. Yamauchi Y, Ejiri Y, Tanaka K (2002) Glycation by ascorbic acid causes loss of activity of ribulose-1,5-bisphosphate carboxylase/oxygenase and its increased susceptibility to proteases. Plant Cell Physiol 43(11):1334–1341PubMedCrossRefGoogle Scholar
  37. Yang J, Zhao J, Xiao H, Zhang D, Li G (2011) Study of hemoglobin and human serum albumin glycation with electrochemical techniques. Electroanalysis 23(2):463–468CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Taqi Ahmed Khan
    • 1
  • M. Saleemuddin
    • 2
  • Aabgeena Naeem
    • 1
  1. 1.Department of Biochemistry, Faculty of Life SciencesAligarh Muslim UniversityAligarhIndia
  2. 2.Interdisciplinary Biotechnology UnitAligarh Muslim UniversityAligarhIndia

Personalised recommendations